English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment Journal article
Xu, Feng, Tong, Man, Tong, Cindy S.W., Chan, Becky K.C., Chu, Hoi Yee, Wong, Tin Lok, Fong, John H.C., Cheung, Maggie S.H., Mak, Kylie Hin Man, Pardeshi, Lakhansing, Huang, Yuanhua, Wong, Koon Ho, Choi, Gigi C.G., Ma, Stephanie, Wong, Alan S.L.. A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment[J]. Cancer Research, 2021, 81(24), 6219-6232.
Authors:  Xu, Feng;  Tong, Man;  Tong, Cindy S.W.;  Chan, Becky K.C.;  Chu, Hoi Yee; et al.
Favorite | TC[WOS]:15 TC[Scopus]:18  IF:12.5/11.6 | Submit date：2022/05/11
Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9 Journal article
Gigi C. G. Choi, Peng Zhou, Chaya T. L. Yuen, Becky K. C. Chan, Feng Xu, Siyu Bao, Hoi Yee Chu, Dawn Thean, Kaeling Tan, Koon Ho Wong, Zongli Zheng, Alan S. L. Wong. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9[J]. NATURE METHODS, 2019, 16(8), 722–730.
Authors:  Gigi C. G. Choi;  Peng Zhou;  Chaya T. L. Yuen;  Becky K. C. Chan;  Feng Xu; et al.
Favorite | TC[WOS]:39 TC[Scopus]:42  IF:36.1/45.6 | Submit date：2020/05/21